Remaining Time

Fehmi Mercanoğlu

Professor Dr. Fehmi Mercanoğlu was born in Istanbul in 1963. He took his graduation from Cerrahpaşa Faculty of Medicine in 1986. In the same year he started his medical specialist training in the Department of Internal Medicine at Cerrahpaşa Faculty of Medicine. In 1991, he became an Internal Medicine Specialist, with his thesis titled "Advancement of Precordial ST Depression in Acute Inferior Myocardial Infarction: Evaluation of 91 Patients with Electrocardiographic Analysis, CPK Enzyme Values ​​and Early Complications".
Between 1991-1992, he completed his obligatory service at Reşadiye State Hospital as an Internal Medicine Specialist. In 1992, he commenced his second specialist training in the Department of Cardiology at Istanbul Faculty of Medicine. In 1995, upon defending his thesis titled "Determination and Investigation of Myocardial Damage caused by Radiofrequency Catheter Ablation by using Troponin T and other Myocardial Enzymes" he was appointed as a cardiology specialist in the same department. Dr. Mercanoğlu became an associate professor in 1998 and professor in 2005. Currently he is serving as a professor of cardiology in İstanbul Faculty of Medicine.
Dr. Mercanoğlu is (co)author of more than 200 publications, 60 of which were published in international refereed journals. He is also author of some chapters in scientific books. He has editorial board membership in scientific journals, and act as a supervisor for various international projects. He is a member of the European Society of Cardiology and the Turkish Society of Cardiology. 

Oral Health and Cardiovascular System

The close relationship between oral health and cardiovascular diseases necessitates frequent co-operation between dentists and cardiologists. In patients with coronary artery and valvular heart disease, invasive dental and gingival interventions are the most prevalent clinical conditions that make this collaboration essential. Recently, the intensity and diversity of antiaggregant and anticoagulant treatments used in the therapy of ischemic heart disease and other atherothrombotic diseases have increased. This situation has increased the risk of hemorrhage in planned dental interventions, and the management of antiplatelet and anticoagulant therapy in perioperative period has become a major challenge. Existing data suggest that most dental interventions can be performed safely under antithrombotic therapy. However, in specific conditions such as more invasive procedure and high risk of haemorrhage, more complex approaches are required. 
Another condition that requires cardiology consultation in dental interventions is infective endocarditis prophylaxis in patients with valvular and congenital heart diseases. Endocarditis risk is not only limited to invasive dental procedure, but may also be relevant to chronic dental inflammatory conditions. 
Epidemiological and observational data suggest that chronic periodontitis and dental infections are more prevalent in patients with coronary artery disease and stroke. Presumed mechanism is the promoting effect of chronic systemic inflammation on atherosclerosis. However, definite cause-effect relationship between chronic periodontitis and heart disease has not been established yet. Therefore, additional studies are required for revealing and better understanding the relation between chronic periodontal inflammation and cardiovascular disease.